Loading...
Accuray Incorporated
ARAY•NASDAQ
Healthcare
Medical - Devices
$0.31
$0.00(0.10%)
U.S. Market opens in 1h 8mAdvertisement
Accuray Incorporated (ARAY) AI-Powered Stock Analysis
See how Accuray Incorporated scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerAccuray Incorporated (ARAY) Stock Overall Grade
Accuray Incorporated’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Accuray Incorporated's overall stock rating.
Forecast
C+Score
52/100Financial Growth
BScore
65/100Fundamental Growth
CScore
40/100Key Ratios
CScore
42/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
99/100Analyst Consensus
C+Score
58/100Accuray Incorporated (ARAY) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 52/100 (C+), reflecting weak confidence in its potential. Financial Growth (65/100, B) and Fundamental Growth (40/100, C) highlight its stability, while Key Ratios (42/100, C) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (99/100, A+), it shows competitive strength. Analyst Consensus (58/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Accuray Incorporated stock grade, including financials, comparisons, and forecasts.